Medicine & Life Sciences
Neoplasms
87%
5'-methylthioadenosine phosphorylase
72%
T-Lymphocytes
64%
Ipilimumab
58%
Tumor Microenvironment
54%
Folic Acid Antagonists
48%
Pemetrexed
46%
Interleukin-7
45%
Therapeutics
41%
Cisplatin
35%
Cell- and Tissue-Based Therapy
33%
Cold Temperature
31%
Carcinoma
30%
Immunotherapy
30%
Prostatic Neoplasms
27%
Tumor-Infiltrating Lymphocytes
26%
Enzymes
22%
Genes
21%
Prostate
19%
Clinical Trials
17%
Melanoma
16%
Nivolumab
15%
purine
13%
Urologic Neoplasms
10%
Protein-Arginine N-Methyltransferases
10%
Interferon-gamma
10%
Immunosuppressive Agents
9%
Purinergic P1 Receptors
8%
Synthetic Lethal Mutations
8%
Macrophages
8%
tremelimumab
7%
durvalumab
7%
Perforin
7%
Neoplasm Metastasis
7%
Leukocytes
6%
Adenine
6%
Adoptive Transfer
6%
Adenocarcinoma of Lung
6%
atezolizumab
6%
Biomarkers
6%
Hydronephrosis
5%
Safety
5%
DNA Damage
5%
Neoadjuvant Therapy
5%
Physics & Astronomy
therapy
100%
tumors
83%
cancer
54%
purines
26%
leukocytes
16%
lethality
13%
adenines
11%
immunosuppression
11%
nucleotides
10%
cultured cells
10%
sensitivity
10%
lungs
9%
enzymes
9%
activation
9%
phenotype
8%
deletion
8%
deoxyribonucleic acid
7%
biomarkers
7%
stratification
6%
pretreatment
6%
synthesis
6%
cells
6%
damage
6%
proportion
5%